Showing 11-20 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Co-transplantation of adaptive human endothelium and islets within encapsulated angiogenic hydrogels for durable engraftment | Weill Medical College of Cornell University | Shahin Rafii | Cures | 01-December-2023 to 30-November-2026 | $1,000,000.00 |
| Role of oxidative post-translational modifications in generating neoepitopes | Weill Medical College of Cornell University | Laura Santambrogio | Cures | 01-April-2025 to 31-March-2028 | $600,000.00 |
| Intrinsic Tolerance in GINS: Dissecting the HVEM/BTLA Axis Driving Hypoimmunogenicity | Weill Medical College of Cornell University | Anna Ada Dattoli | Cures | 01-April-2026 to 31-March-2027 | $199,999.32 |
| A Novel Ultra-Rapid Insulin | Wayne State University | Zhiqiang Cao | Improving Lives | 01-November-2025 to 31-October-2026 | $299,994.92 |
| Orally Delivered Glucose-Responsive Insulin | Wayne State University | Zhiqiang Cao | Improving Lives | 01-June-2024 to 31-May-2026 | $274,499.13 |
| Assess the antigenic profile in human T1D: from β-cell crinophagy to peripheral blood | Washington University | Xiaoxiao Wan | Cures | 01-April-2022 to 31-March-2027 | $750,000.00 |
| Enhancing Human Stem Cell-Derived Islet Survival and Function Using SA-PD-L1-Presenting Microgels | Washington University | Jeffrey Millman | Cures | 01-August-2024 to 31-July-2027 | $1,125,000.00 |
| Genetic Engineering to Improve Engraftment of Stem Cell-Derived Islets | Washington University | Jeffrey Millman | Cures | 01-February-2023 to 31-January-2026 | $450,000.00 |
| Overcoming Production Barriers to Stem Cell-Islet Therapies Through Scalable Technologies | Washington University | Jeffrey Millman | Cures | 01-March-2026 to 29-February-2028 | $550,000.00 |
| Combining Arteriovenous Bundle and ECM-Based Biomaterial Technologies to Induce Potent Neovascularization Following Islet Transplantation | Wake Forest University Health Sciences | Giuseppe Orlando | Cures | 01-April-2025 to 31-March-2027 | $248,692.00 |